Key result
VATS left cardiac sympathetic denervation is safely performed without complications in pediatric Jervell and Lange-Nielsen syndrome.
Why the study?
Jervell and Lange-Nielsen syndrome carries a very high risk of torsades de pointes and sudden cardiac death from early childhood. A large proportion of patients remain symptomatic despite first-line beta-blockade, and left cardiac sympathetic denervation is recommended as an adjunct in high-risk or breakthrough disease.
Case Report (n=1)
No
This case report demonstrates that video-assisted thoracoscopic left cardiac sympathetic denervation can be performed safely and without complication in a very young, low-weight (13 kg) child with high-risk Jervell and Lange-Nielsen syndrome when supported by a structured, electrolyte-focused multidisciplinary perioperative pathway.
Answers are grounded in this paper and cite their sources.
Supports feasibility of thoracoscopic LCSD in young children with JLNS; hypothesis-generating for pediatric efficacy trials.
Introduction: Jervell and Lange-Nielsen syndrome (JLNS) is a rare autosomal recessive channelopathy caused by biallelic loss-of-function variants in KCNQ1 (or, less commonly, KCNE1), producing profound congenital sensorineural deafness together with a markedly prolonged QT interval and a very high risk of torsades de pointes and sudden cardiac death from early childhood. Beta-blockade is first-line therapy, but a large proportion of patients remain symptomatic, and left cardiac sympathetic denervation (LCSD) is recommended as an adjunct in high-risk or breakthrough disease. Case presentation: We describe a 4-year-1-month-old girl from rural Punjab, Pakistan, with genetically confirmed KCNQ1-related JLNS, who presented with recurrent seizure-like episodes from one year of age, profound bilateral sensorineural deafness with absent expressive speech, divergent squint, and a family history of a sibling who died at 5.5 months of age during an uncontrolled seizure/collapse. Despite oral propranolol and antiepileptic therapy, she remained at high arrhythmic risk on multidisciplinary review and underwent elective video-assisted thoracoscopic (VATS) left cardiac sympathetic denervation. Clinical discussion: Baseline transthoracic echocardiography confirmed a structurally normal heart with preserved biventricular function, in keeping with a pure electrical (channelopathy) substrate. A dedicated perioperative pathway was used: tight target ranges for serum potassium (4.0–5.5 mmol/L) and magnesium (2.0–2.25 mg/dL), continuous ECG telemetry with defibrillator pads applied throughout the admission, bedside emergency antiarrhythmic drugs, and confirmed availability of paediatric thoracoscopic instrumentation and back-up temporary pacing/defibrillation. Surgery — resection of the lower third of the left stellate ganglion together with the upper thoracic sympathetic chain — was completed via a three-port VATS approach without intraoperative complication, inotropic support, or need for conversion. Conclusion This case illustrates that VATS-LCSD can be performed safely in a small child (13 kg) with high-risk JLNS when supported by careful multidisciplinary perioperative planning, and reinforces the importance of genetic counselling and cascade screening in families with unexplained infant deaths.
No takes yet. Share an insight, caveat, or question.
Saad Rehman (2026) conducted a case report in Jervell and Lange-Nielsen syndrome (KCNQ1-related long QT syndrome) (n=1). Video-assisted thoracoscopic left cardiac sympathetic denervation (VATS-LCSD) as an adjunct to oral propranolol was evaluated on Perioperative safety, technical feasibility, and absence of intraoperative or immediate postoperative complications/arrhythmias. Video-assisted thoracoscopic left cardiac sympathetic denervation was safely performed without arrhythmias or complications in a 4-year-old, 13 kg girl with Jervell and Lange-Nielsen syndrome.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: